PGT-CompleteSM Test

Right Embryo
Advancing Standards of Care with our four-in-one genetic test

PGT-CompleteSM Test

Right Embryo
Advancing Standards of Care with our four-in-one genetic test

PGT-Complete is our most comprehensive PGT-A test

The PGT-Complete test provides our most comprehensive screening of your embryos,
allowing you and your physician to make fully-informed embryo transfer decisions.

PGT-A
All the benefits of our innovative PGTai® 2.0 platform helps to improve the chances of IVF success²

Parental QC*
Reassures you and your clinical team that the correct egg and sperm were used, helping avoid mix-ups and reducing anxiety

Genetic PN check
May provide you with additional embryos for transfer by helping healthcare providers confirm that correct fertilization took place

Origin of aneuploidy
Identifies if the abnormality is originating from the sperm or the egg; allowing you and your clinical team to consider donor gamete options

” Keep up this great work!

It is especially impressive with the amount of data you have. It gives great confidence to clinicians and ultimately our patients! “

Karen Sage, MSc, GC, Co-Founder, Fertility Genetics

Watch our PGT-Complete Webinar

How is our PGT-A test different?

CooperSurgical® uses artificial intelligence (PGTai® Platform) to analyze your embryo data

How our test works

Our artificial intelligence platform is based on thousands of embryos that resulted in healthy live births. The chromosomal status of your embryo is checked against the data taken from these embryos, improving the accuracy of our test.

How PGTai® Platform benefits you compared to other PGT-A technology

  • Has been shown to increase ongoing pregnancy and live birth rates2
  • Biochemical pregnancy loss rates and spontaneous abortion reduced2
  • More euploid embryos available for transfer4

Parental QC*

Reassuring you by confirming the correct egg and sperm have been used

Today’s IVF patient is more educated, motivated, and involved in their treatment than ever before. The Parental QC test feature confirms a match** between the embryo biopsy sample and the provided patient samples through DNA fingerprinting. DNA fingerprinting allows us to match each sample to a unique individual. This reduces the anxiety of potential mix-ups.


* Parental QC is not reported in countries where it is not permitted by regulatory bodies.
**A match is defined as a genetic analysis that is consistent with a shared inheritance and familial relationship between the parental samples and the embryo biopsy sample

Genetic PN check

Empowering additional embryo transfers

Empowering your clinical team with additional embryos for transfer with Genetic PN (pronuclear) checking, you can feel confident that all available euploid embryos are given every opportunity to be genetically tested, increasing transfer potential. Moreover, if you have a history of triploid loss or a partial/molar pregnancy, Genetic PN checking may help to avoid these challenges on your next transfer.

Origin of aneuploidy

Helping you make informed donor gamete decisions

Origin of aneuploidy helps you, your partner and clinical team make decisions as to whether a gamete donor is right for you by determining where the chromosomal abnormality comes from, the sperm or egg. By doing so, couples can reduce the number of IVF cycles undertaken, lower the time to pregnancy and reduce stress associated with treatment.

For patients considering donor gametes it is important to understand that not all aneuploidy is maternally derived, as often paternal contribution to aneuploidy can be overlooked.

Simple test process

Designed with the patient in mind every step of the way

At CooperSurgical, we recognize that each sample that comes through our laboratory belongs to an individual or family with their own unique story and journey. We take a personalized approach to patient care and clinical service.

PGT-Complete selected on test requistion form

Embryo biopsy and parental cheek (buccal) swabs collected & shipped to CooperGenomics

Samples analyzed and reported back to the clinic

Genetic testing consultation is available before or after testing

Documents

1. JBRA Assist Reprod. 2020 Apr-Jun; 24(2): 143–146. Blastocysts Derived From 0PN Oocytes: Genetic And Clinical Results

2. Buldo-Licciardi J, Large M, McCulloh D, McCaffrey C, Grifo J. Second generation artificial intelligence technology for preimplantation genetic testing (PRT) improves pregnancy outcomes in single thawed euploid embryo transfer cycles (STEET).
Presented at American Society for Reproductive Medicine on October 19, 2020. Available at: https://asrm.confex.com/asrm/2020/meetingapp.cgi/Paper/8645. Accessed Feb 18, 2022.

3. CooperGenomics, internal data on file.